Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer
International Journal of Molecular Sciences · 14.09.2025 · 26 (18) · 8944
DOI: 10.3390/ijms26188944 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.09.2025. Verfasst von Burak İlhan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Early detection of breast cancer (BC) remains a challenge despite advances in screening, leading to poor prognosis in late-stage disease. Circulating microRNAs (miRNAs) have emerged as promising non-invasive biomarkers for early diagnosis. The study aimed to evaluate the diagnostic utility of serum miR-197-3p, miR-1236, and miR-1271 levels in distinguishing BC patients from healthy individuals. Serum samples from 92 BC patients and 31 healthy controls were analyzed. Total RNA was extracted, and miRNA expression levels were quantified using quantitative real-time PCR (qRT-PCR). Expression differences were assessed using the ΔCt method. Receiver Operating Characteristic (ROC) curve analysis evaluated diagnostic performance. Serum miR-197-3p levels were significantly upregulated (fold change = 8.939, p = 0.0048), while miR-1236 was downregulated (fold change = 0.112, p = 0.0029) in BC patients. miR-1271 showed no significant association. miR-1236 demonstrated superior diagnostic performance (AUC = 0.731, sensitivity = 80.7%, specificity = 51.3%) compared to miR-197-3p (AUC = 0.667, sensitivity = 67.0%, specificity = 45.6%). The combination of miR-197-3p and miR-1236 improved diagnostic accuracy (AUC = 0.842, CI: 0.764–0.936). Serum miR-197-3p and miR-1236 hold promise as complementary biomarkers for early BC detection. Larger multicenter studies are warranted to validate their clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye.
- Department of Medical Biochemistry, Hamidiye Faculty of Medicine, University of Health Sciences, 34668 Istanbul, Türkiye.
- Department of Surgery, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.
- Department of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.
- Department of Medical Biology, International School of Medicine, University of Health Sciences, 34668 Istanbul, Türkiye.
- Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye.
ORCID-Profile: Burak İlhan, Sibel Kuraş, Berkay Kılıç, Ceren Tilgen Yasasever, Hilal Oğuz Soydinç, Gözde Öztan, Arash Adamnejad Ghafour, Muhammed Ucuncu
Zitieren
APA
İlhan, B., Kuraş, S., Kılıç, B., Tilgen Yasasever, C., Oğuz Soydinç, H., Alsaadoni, H., Öztan, G., Adamnejad Ghafour, A., Ucuncu, M., Kunduz, E., & Bademler, S. (2025). Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer. International Journal of Molecular Sciences, 26(18), 8944. https://doi.org/10.3390/ijms26188944
Vancouver
İlhan B, Kuraş S, Kılıç B, Tilgen Yasasever C, Oğuz Soydinç H, Alsaadoni H, et al. Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer. International Journal of Molecular Sciences. 2025;26(18):8944. doi:10.3390/ijms26188944
BibTeX
@article{lhan2025,
author = {İlhan, Burak and Kuraş, Sibel and Kılıç, Berkay and Tilgen Yasasever, Ceren and Oğuz Soydinç, Hilal and Alsaadoni, Hani and Öztan, Gözde and Adamnejad Ghafour, Arash and Ucuncu, Muhammed and Kunduz, Enver and Bademler, Süleyman},
title = {Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {18},
pages = {8944},
doi = {10.3390/ijms26188944}
}
EUVIMED